Guardant Health (GH) Tops Q4 EPS by 46c

Guardant Health (NASDAQ: GH) reported Q4 EPS of ($0.69), $0.46 better than the analyst estimate of ($1.15). Revenue for the quarter came in at $108 million versus the consensus estimate of $98.61 million.

GUIDANCE:

Guardant Health sees FY2022 revenue of $460-470 million, versus the consensus of $471 million.

For earnings history and earnings-related data on Guardant Health (GH) click here.

You May Also Be Interested In

• Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
• Keurig Dr Pepper coffee chief to depart ahead of planned split
• AeroVironment restates quarterly financials, citing $89M goodwill error